Ankylosing Spondylitis Clinical Trials

32 recruiting

Ankylosing Spondylitis Trials at a Glance

47 actively recruiting trials for ankylosing spondylitis are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Beijing, Kırşehir, and Seoul. Lead sponsors running ankylosing spondylitis studies include China-Japan Friendship Hospital, Kirsehir Ahi Evran Universitesi, and Nanfang Hospital, Southern Medical University.

Browse ankylosing spondylitis trials by phase

Treatments under study

About Ankylosing Spondylitis Clinical Trials

Looking for clinical trials for Ankylosing Spondylitis? There are currently 32 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ankylosing Spondylitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ankylosing Spondylitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 47 trials

Recruiting

Oxidative Stress in Autoimmune Rheumatic Diseases

Psoriatic Arthritis (PsA)Ankylosing Spondylitis (AS)Rheumatoid Arthritis (RA)+1 more
University of Thessaly200 enrolled1 locationNCT07536529
Recruiting

Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study

Ankylosing Spondylitis (AS)
China-Japan Friendship Hospital790 enrolled1 locationNCT07556224
Recruiting

The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study

Ankylosing Spondylitis (AS)Axial Spondyloarthritis
China-Japan Friendship Hospital2,250 enrolled1 locationNCT06844643
Recruiting

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

Ankylosing Spondylitis (AS)
China-Japan Friendship Hospital210 enrolled1 locationNCT07509775
Recruiting

Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis

Ankylosing SpondylitisLow Back Pain
Konya Beyhekim Training and Research Hospital200 enrolled1 locationNCT07510789
Recruiting

Korean Post-marketing Surveillance for Xeljanz XR

Active Moderate to Severe Rheumatoid ArthritisActive Ankylosing SpondylitisActive Psoriatic Arthritis
Pfizer200 enrolled1 locationNCT04876781
Recruiting
Not Applicable

Deep Breathing Combined With Core Stability Exercises in the Treatment of Patients With Ankylosing Spondylitis

Ankylosing Spondylitis (AS)
Beni-Suef University30 enrolled1 locationNCT07262294
Recruiting

Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.

Ankylosing Spondylitis
Novartis Pharmaceuticals70 enrolled2 locationsNCT06905288
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Not Applicable

Clinical Trial Study on the Improved New Method of Acupotomy for AS

Ankylosing Spondylitis
Henan Provincial People's Hospital60 enrolled1 locationNCT07390929
Recruiting
Phase 4

A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis

Ankylosing Spondylitis (AS)
Tongji Hospital100 enrolled3 locationsNCT05303285
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+14 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting

Biomarkers in Ankylosing Spondylitis

Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
Kirsehir Ahi Evran Universitesi160 enrolled1 locationNCT07117344
Recruiting
Phase 3

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Active Ankylosing Spondylitis
Jiangsu vcare pharmaceutical technology co., LTD420 enrolled1 locationNCT07172360
Recruiting

Exactech Shoulder Post Market Clinical Follow-up Study

Rheumatoid ArthritisInfectionsAnkylosing Spondylitis+6 more
Exactech20,000 enrolled38 locationsNCT05603728
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)

Ankylosing Spondylitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.500 enrolled1 locationNCT07261644
Recruiting
Phase 2

Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases

Rheumatoid ArthritisAnkylosing SpondylitisCrohn Disease+2 more
Odense University Hospital200 enrolled1 locationNCT04924270
Recruiting

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

Celiac DiseaseMultiple SclerosisAnkylosing Spondylitis+6 more
TScan Therapeutics, Inc.300 enrolled12 locationsNCT06587828
Recruiting
Phase 3

A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis

Ankylosing Spondylitis
Lynk Pharmaceuticals Co., Ltd352 enrolled1 locationNCT07237568
Recruiting

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

MelanomaRheumatoid ArthritisAnkylosing Spondylitis+10 more
M.D. Anderson Cancer Center125 enrolled1 locationNCT04751396